{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:04:16Z","timestamp":1794629056034,"version":"4.9.1"},"reference-count":382,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110527","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T18:55:54Z","timestamp":1748026554000},"page":"110527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The neuroprotective effects of N-acetylcysteine in psychiatric and neurodegenerative disorders: From modulation of glutamatergic transmission to restoration of synaptic plasticity"],"prefix":"10.1016","volume":"278","author":[{"given":"Suwarna","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.S.","family":"Shankaranarayana Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Jamuna","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.neuropharm.2025.110527_bib1","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mds.22589","article-title":"Neuropsychiatric symptoms in Parkinson's disease","volume":"24","author":"Aarsland","year":"2009","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012490","article-title":"Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats","volume":"5","author":"Abdel Baki","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2025.110527_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-10-42","article-title":"Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats","volume":"10","author":"Aldbass","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"16","key":"10.1016\/j.neuropharm.2025.110527_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612733","article-title":"N-acetylcysteine amide against abeta-induced alzheimer's-like pathology in rats","volume":"24","author":"Alkandari","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1192\/bjp.bp.115.180059","article-title":"Risk of dementia and death in community-dwelling older men with bipolar disorder","volume":"209","author":"Almeida","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.euroneuro.2021.10.002","article-title":"A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smoking","volume":"53","author":"Arancini","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuint.2012.07.024","article-title":"Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats","volume":"61","author":"Arent","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2025.110527_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpsychires.2015.04.011","article-title":"The effects of n-acetylcysteine and\/or deferoxamine on manic-like behavior and brain oxidative damage in mice submitted to the paradoxal sleep deprivation model of mania","volume":"65","author":"Arent","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114740","article-title":"N-acetylcysteine ameliorates chemotherapy-induced impaired anxiety and depression-like behaviors by regulating inflammation, oxidative and cholinergic status, and BDNF release","volume":"458","author":"Aslanlar","year":"2024","journal-title":"Behav. Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib12","doi-asserted-by":"crossref","first-page":"e1439","DOI":"10.4088\/JCP.15m10239","article-title":"A double-blind, randomized, controlled pilot trial of N-acetylcysteine in veterans with posttraumatic stress disorder and substance use disorders","volume":"77","author":"Back","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib13","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1301532","article-title":"Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine","volume":"33","author":"Baker","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"20","key":"10.1016\/j.neuropharm.2025.110527_bib15","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002","article-title":"The origin and neuronal function of in vivo nonsynaptic glutamate","volume":"22","author":"Baker","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib16","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","article-title":"Exchange of cystine and glutamate across plasma membrane of human fibroblasts","volume":"261","author":"Bannai","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41398-024-02822-1","article-title":"Causal influences of neuropsychiatric disorders on Alzheimer's disease","volume":"14","author":"Baranova","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1113\/jphysiol.1991.sp018901","article-title":"Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus","volume":"444","author":"Baskys","year":"1991","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006591","article-title":"Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons","volume":"4","author":"Battaglia","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jalz.2016.07.152","article-title":"Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses","volume":"13","author":"Bellou","year":"2017","journal-title":"Alzheimer's Dement."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-1211(00)00096-6","article-title":"Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies","volume":"40","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsat.2015.12.003","article-title":"Low pretreatment impulsivity and high medication adherence increase the odds of abstinence in a trial of N-acetylcysteine in adolescents with cannabis use disorder","volume":"63","author":"Bentzley","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2025.110527_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","article-title":"The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial","volume":"135","author":"Berk","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.13m08454","article-title":"The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial","volume":"75","author":"Berk","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12916-019-1280-2","article-title":"Correction to: a randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo","volume":"17","author":"Berk","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2025.110527_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2015.10.011","article-title":"Mitochondrial fusion\/fission dynamics in neurodegeneration and neuronal plasticity","volume":"90","author":"Bertholet","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2025.110527_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fneur.2017.00744","article-title":"Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) in traumatic brain injury: impact on neurofunctional outcome and biomarkers of oxidative stress and inflammation","volume":"8","author":"Bhatti","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107144","article-title":"N-acetyl cysteine: a new look at its effect on PTZ-induced convulsions","volume":"193","author":"Bilister Egilmez","year":"2023","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0003-9861(57)90218-7","article-title":"Quantitative nutritional studies with water-soluble, chemically defined diets. III. Individual amino acids as sources of non-essential nitrogen","volume":"72","author":"Birnbaum","year":"1957","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2025.110527_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.84","article-title":"Traumatic brain injuries","volume":"2","author":"Blennow","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2025.110527_bib35","first-page":"45","article-title":"Toxicological, pharmacokinetic and metabolic studies on acetylcysteine","volume":"111","author":"Bonanomi","year":"1980","journal-title":"Eur. J. Respir. Dis. Suppl."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41416-020-01156-1","article-title":"Cysteine metabolic circuitries: druggable targets in cancer","volume":"124","author":"Bonifacio","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstrom","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib38","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00213-015-4179-4","article-title":"N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice","volume":"233","author":"Bowers","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"11\u201312","key":"10.1016\/j.neuropharm.2025.110527_bib40","first-page":"960","article-title":"N-acetylcysteine slows down ageing and increases the life span of Drosophila melanogaster","volume":"53","author":"Brack","year":"1997","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110527_bib41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fncel.2015.00476","article-title":"Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation","volume":"9","author":"Brites","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087321","article-title":"Chronic N-Acetyl-Cysteine treatment enhances the expression of the immediate early gene Nr4a1 in response to an acute challenge in male rats: comparison with the antidepressant venlafaxine","volume":"24","author":"Brivio","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib43","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1476-5381.1996.tb15306.x","article-title":"Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices","volume":"117","author":"Bushell","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib44","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.neuron.2014.07.028","article-title":"Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia","volume":"83","author":"Cabungcal","year":"2014","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib45","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2012.09.020","article-title":"Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine","volume":"73","author":"Cabungcal","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib46","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.2147\/NDT.S172933","article-title":"Schizophrenia and risk of dementia: a meta-analysis study","volume":"14","author":"Cai","year":"2018","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib47","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/jnr.24736","article-title":"Efficacy of N-acetylcysteine in the prevention of alcohol relapse-like drinking: study in long-term ethanol-experienced male rats","volume":"99","author":"Cano-Cebrian","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuroscience.2012.06.044","article-title":"N-acetylcysteine reverses existing cognitive impairment and increased oxidative stress in glutamate transporter type 3 deficient mice","volume":"220","author":"Cao","year":"2012","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","article-title":"Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms","volume":"70","author":"Capuron","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12061257","article-title":"N-acetylcysteine treatment may compensate motor impairments through dopaminergic transmission modulation in a striatal 6-hydroxydopamine Parkinson's disease rat model","volume":"12","author":"Caridade-Silva","year":"2023","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110527_bib51","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0006-3223(99)00117-1","article-title":"Neurotransmitter interactions in schizophrenia--therapeutic implications","volume":"46","author":"Carlsson","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/JCP.0b013e31829839c6","article-title":"N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression","volume":"33","author":"Carvalho","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0893-133X(98)00050-5","article-title":"Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys","volume":"20","author":"Castner","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110527_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113507","article-title":"N-acetylcysteine reduces brain injury after delayed hypoxemia following traumatic brain injury","volume":"335","author":"Celorrio","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110000","article-title":"Brain stimulation rewarding experience attenuates neonatal clomipramine-induced adulthood anxiety by reversal of pathological changes in the amygdala","volume":"103","author":"Chakraborty","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110527_bib56","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s00213-020-05585-x","article-title":"Mechanisms underlying remediation of depression-associated anxiety by chronic N-acetyl cysteine treatment","volume":"237","author":"Chakraborty","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110527_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104605","article-title":"N-acetyl cysteine ameliorates depression-induced cognitive deficits by restoring the volumes of hippocampal subfields and associated neurochemical changes","volume":"132","author":"Chakraborty","year":"2020","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1533317508325093","article-title":"Efficacy of a vitamin\/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension","volume":"23","author":"Chan","year":"2008","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.neuropharm.2025.110527_bib59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuropharm.2018.03.021","article-title":"The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats","volume":"135","author":"Charntikov","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0891988718783897","article-title":"Neuropsychiatric symptoms and caregiver burden in individuals with alzheimer's disease: the TEAM-AD VA cooperative study","volume":"31","author":"Chen","year":"2018","journal-title":"J. Geriatr. Psychiatr. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib61","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1471-4159.2003.01630.x","article-title":"The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures","volume":"84","author":"Chen","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110527_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fnbeh.2014.00219","article-title":"Activation of mGluR2\/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism","volume":"8","author":"Chen","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib63","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41593-019-0505-1","article-title":"Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence","volume":"22","author":"Chow","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib64","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.2174\/1570159X2108230510162504","article-title":"Epilepsy and related neuropsychiatric comorbidities: basic and clinical research","volume":"21","author":"Citraro","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice","volume":"5","author":"Clark","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180280","article-title":"Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children","volume":"12","author":"Clark","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib67","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s13311-023-01422-z","article-title":"N-acetylcysteine and probenecid adjuvant therapy for traumatic brain injury","volume":"20","author":"Clark","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib68","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.freeradbiomed.2004.11.034","article-title":"Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine","volume":"38","author":"Cocco","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2025.110527_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pnpbp.2013.02.008","article-title":"Interactive effects of N-acetylcysteine and antidepressants","volume":"44","author":"Costa-Campos","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib70","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.4088\/JCP.16m11101","article-title":"Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder","volume":"78","author":"Costa","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-2952(91)90674-T","article-title":"The metabolism of N-acetylcysteine by human endothelial cells","volume":"42","author":"Cotgreave","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1462612","article-title":"Effect of N-acetylcysteine on craving in substance use disorders (SUD): a meta-analysis of randomized controlled trials","volume":"15","author":"Cuocina","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.artd.2020.03.010","article-title":"N-Acetyl-Cysteine reduces blood chromium and cobalt levels in metal-on-metal hip arthroplasty","volume":"6","author":"D'Ambrosi","year":"2020","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.neuropharm.2025.110527_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbi.2017.05.008","article-title":"N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin","volume":"272","author":"da Costa","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib75","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopsych.2011.07.035","article-title":"N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development","volume":"71","author":"das Neves Duarte","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yebeh.2017.12.025","article-title":"Oxidative stress in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis: possible association with major depressive disorder?","volume":"80","author":"de Araujo Filho","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib77","article-title":"The impacts of adolescent cannabinoid exposure on striatal anxiety- and depressive-like pathophysiology are prevented by the antioxidant N-acetylcysteine","volume":"4","author":"De Felice","year":"2024","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib79","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1440-1819.2012.02392.x","article-title":"Effects of N-acetyl cysteine on cognitive function in bipolar disorder","volume":"66","author":"Dean","year":"2012","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2011.05.027","article-title":"N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder","volume":"499","author":"Dean","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110527_bib81","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High-dose acetylcysteine in idiopathic pulmonary fibrosis","volume":"353","author":"Demedts","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib82","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/jcb.21739","article-title":"The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of hippocampal neural cells","volume":"104","author":"Demiralay","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib83","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jagp.2019.08.006","article-title":"The interplay between post-traumatic stress disorder and dementia: a systematic review","volume":"28","author":"Desmarais","year":"2020","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib84","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.biopsych.2021.02.970","article-title":"Activating mGlu(3) metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the Hippocampus","volume":"90","author":"Dogra","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080138","article-title":"Effects of antioxidant treatment on blast-induced brain injury","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib86","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajad.12620","article-title":"N-acetylcysteine in the treatment of craving in substance use disorders: systematic review and meta-analysis","volume":"26","author":"Duailibi","year":"2017","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib87","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biopsych.2015.09.019","article-title":"N-Acetylcysteine facilitates self-imposed abstinence after escalation of cocaine intake","volume":"80","author":"Ducret","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090617","article-title":"Efficacy of N-acetyl cysteine in traumatic brain injury","volume":"9","author":"Eakin","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib89","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.59.9.1447","article-title":"N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects","volume":"59","author":"Edwards","year":"2002","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib90","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s11064-020-03042-x","article-title":"Combination therapy of gabapentin and N-acetylcysteine against posttraumatic epilepsy in rats","volume":"45","author":"Efendioglu","year":"2020","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/rccm.201802-0245OC","article-title":"An improved inhaled mucolytic to treat airway muco-obstructive diseases","volume":"199","author":"Ehre","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib92","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/01616412.2024.2325312","article-title":"N-acetylcysteine increases dopamine release and prevents the deleterious effects of 6-OHDA on the expression of VMAT2, alpha-synuclein, and tyrosine hydroxylase","volume":"46","author":"El-Habta","year":"2024","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib93","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jad.2018.10.083","article-title":"The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: a randomized placebo-controlled study","volume":"245","author":"Ellegaard","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib94","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3171\/jns.1991.75.5.0774","article-title":"Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger n-acetylcysteine following experimental traumatic brain injury","volume":"75","author":"Ellis","year":"1991","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib95","first-page":"201","article-title":"Pathophysiology of epilepsy","volume":"100","author":"Engelborghs","year":"2000","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neuropharm.2025.110527_bib96","article-title":"N-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder","volume":"15","author":"Engeli","year":"2024","journal-title":"Front. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib97","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0378-4347(96)00196-X","article-title":"High-performance liquid chromatography assay for N-acetylcysteine in biological samples following derivatization with N-(1-pyrenyl)maleimide","volume":"685","author":"Ercal","year":"1996","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.neuropharm.2025.110527_bib98","series-title":"In StatPearls","article-title":"N-Acetylcysteine","author":"Ershad","year":"2024"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib99","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chembiol.2018.01.011","article-title":"N-acetyl cysteine functions as a fast-acting antioxidant by triggering intracellular H(2)S and sulfane sulfur production","volume":"25","author":"Ezerina","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib100","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","article-title":"The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice","volume":"84","author":"Farr","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110527_bib101","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbr.2019.02.025","article-title":"N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat","volume":"364","author":"Fernandes","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib102","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1523\/JNEUROSCI.15-04-02857.1995","article-title":"N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells","volume":"15","author":"Ferrari","year":"1995","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib103","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/FBP.0b013e3283123c98","article-title":"Antidepressant-like effects of N-acetyl-L-cysteine in rats","volume":"19","author":"Ferreira","year":"2008","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib104","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.alcohol.2008.12.003","article-title":"Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats","volume":"43","author":"Ferreira Seiva","year":"2009","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110527_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2023.100119","article-title":"Inefficacy of N-acetylcysteine in mitigating cue-induced amphetamine-seeking","volume":"8","author":"Fort","year":"2023","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110527_bib106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbr.2014.02.044","article-title":"The effects of N-acetylcysteine on cocaine reward and seeking behaviors in a rat model of depression","volume":"266","author":"Frankowska","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114089","article-title":"N-acetylcysteine improves impulse control and attenuates relapse-like alcohol intake in long-term drinking rats","volume":"436","author":"Fredriksson","year":"2023","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib108","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2006.06.042","article-title":"Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice","volume":"1109","author":"Fu","year":"2006","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12798","article-title":"N-Acetylcysteine treatment during acute stress prevents stress-induced augmentation of addictive drug use and relapse","volume":"25","author":"Garcia-Keller","year":"2020","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00726-003-0045-5","article-title":"Cysteine-induced hypoglycemic brain damage: an alternative mechanism to excitotoxicity","volume":"26","author":"Gazit","year":"2004","journal-title":"Amino Acids"},{"issue":"10258","key":"10.1016\/j.neuropharm.2025.110527_bib111","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib112","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2468-2667(24)00302-5","article-title":"Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"10","year":"2025","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.neuropharm.2025.110527_bib113","article-title":"N-Acetyl-Cysteine as effective and safe chelating agent in metal-on-metal hip-implanted patients: two cases","volume":"2016","author":"Giampreti","year":"2016","journal-title":"Case Rep Orthop"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib114","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12974-018-1357-4","article-title":"Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?","volume":"15","author":"Gil-Martinez","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019399","article-title":"Support for midlife anxiety diagnosis as an independent risk factor for dementia: a systematic review","volume":"8","author":"Gimson","year":"2018","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib116","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bcp.2012.09.010","article-title":"N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential","volume":"84","author":"Giustarini","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib117","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/mol.117.109926","article-title":"N-Acetyl-l-Cysteine protects astrocytes against proteotoxicity without recourse to glutathione","volume":"92","author":"Gleixner","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib118","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.003","article-title":"Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology","volume":"93","author":"Goldsmith","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib119","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11481-023-10064-z","article-title":"Emphasizing the crosstalk between inflammatory and neural signaling in post-traumatic stress disorder (PTSD)","volume":"18","author":"Govindula","year":"2023","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.2012.12010055","article-title":"A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents","volume":"169","author":"Gray","year":"2012","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110527_bib121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.drugalcdep.2017.04.020","article-title":"A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults","volume":"177","author":"Gray","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib122","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41386-025-02061-y","article-title":"N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings","volume":"50","author":"Gray","year":"2025","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib123","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrn1429","article-title":"The developmental origins of anxiety","volume":"5","author":"Gross","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib124","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pbb.2005.06.019","article-title":"Possible role of free radicals in theophylline-induced seizures in mice","volume":"82","author":"Gulati","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biopsych.2011.09.031","article-title":"Glutamatergic modulation of auditory information processing in the human brain","volume":"71","author":"Gunduz-Bruce","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.expneurol.2013.09.002","article-title":"Minocycline plus N-acetylcysteine synergize to modulate inflammation and prevent cognitive and memory deficits in a rat model of mild traumatic brain injury","volume":"249","author":"Haber","year":"2013","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib127","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/0271678X17718106","article-title":"Minocycline plus N-acteylcysteine induces remyelination, synergistically protects oligodendrocytes and modifies neuroinflammation in a rat model of mild traumatic brain injury","volume":"38","author":"Haber","year":"2018","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib129","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1093\/cercor\/bhac327","article-title":"N-acetylcysteine treatment mitigates loss of cortical parvalbumin-positive interneuron and perineuronal net integrity resulting from persistent oxidative stress in a rat TBI model","volume":"33","author":"Hameed","year":"2023","journal-title":"Cerebr. Cortex"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib130","article-title":"The role of twice-daily N-acetylcysteine (NAC) 2400 mg in smoking cessation: a randomized, placebo-controlled trial in Indonesia","volume":"16","author":"Harlivasari","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/neu.2017.2","article-title":"Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor","volume":"29","author":"Hasebe","year":"2017","journal-title":"Acta Neuropsychiatr."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib132","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/sj.npp.1300512","article-title":"Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine","volume":"29","author":"Hashimoto","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib133","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1474-9726.2012.00792.x","article-title":"Reversal of age-related oxidative stress prevents hippocampal synaptic plasticity deficits by protecting D-serine-dependent NMDA receptor activation","volume":"11","author":"Haxaire","year":"2012","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib134","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2307\/3578727","article-title":"Mechanisms for the oxygen radical-mediated toxicity of various thiol-containing compounds in cultured mammalian cells","volume":"139","author":"Held","year":"1994","journal-title":"Radiat. Res."},{"issue":"6703","key":"10.1016\/j.neuropharm.2025.110527_bib135","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1126\/science.adi3450","article-title":"Neuronal senescence may drive brain aging","volume":"384","author":"Herdy","year":"2024","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib136","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.stem.2022.11.010","article-title":"Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease","volume":"29","author":"Herdy","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110527_bib137","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41386-019-0380-1","article-title":"Group II metabotropic glutamate receptor blockade promotes stress resilience in mice","volume":"44","author":"Highland","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib138","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3945\/ajcn.114.101964","article-title":"Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status","volume":"102","author":"Hildebrandt","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib139","first-page":"43","article-title":"A review of bipolar disorder in adults","volume":"3","author":"Hilty","year":"2006","journal-title":"Psychiatry (Edgmont)"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-9556(25)07834-1","article-title":"3-(glutathion-S-yl)acetaminophen: a biliary metabolite of acetaminophen","volume":"10","author":"Hinson","year":"1982","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2025.110527_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102067","article-title":"CCL5 via GPX1 activation protects hippocampal memory function after mild traumatic brain injury","volume":"46","author":"Ho","year":"2021","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib142","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/ejn.13894","article-title":"Heroin seeking becomes dependent on dorsal striatal dopaminergic mechanisms and can be decreased by N-acetylcysteine","volume":"50","author":"Hodebourg","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib143","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12929-017-0377-1","article-title":"Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine","volume":"24","author":"Hoffer","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054163","article-title":"Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study","volume":"8","author":"Hoffer","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","volume":"20","author":"Holdiness","year":"1991","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib146","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib147","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.nbd.2011.12.031","article-title":"Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model","volume":"45","author":"Hsiao","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib148","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jnr.22422","article-title":"Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP\/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment","volume":"88","author":"Huang","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib149","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.47.5.1264","article-title":"Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine","volume":"47","author":"Hurd","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/clpt.1992.121","article-title":"N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses","volume":"52","author":"Iversen","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110527_bib151","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","article-title":"Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions","volume":"78","author":"Javitt","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib152","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington's disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2025.110527_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7547382","article-title":"Effect of N-acetyl cysteine on intracerebroventricular colchicine induced cognitive deficits, beta amyloid pathology, and glial cells","volume":"2019","author":"Joy","year":"2019","journal-title":"Neurosci J"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib154","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110527_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115398","article-title":"A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD","volume":"327","author":"Kanaan","year":"2023","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib156","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00213-019-05211-5","article-title":"Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates","volume":"236","author":"Kangas","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib157","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S0033291718000831","article-title":"Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study","volume":"49","author":"Kappelmann","year":"2019","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041086","article-title":"Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats","volume":"7","author":"Karalija","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(81)90628-4","article-title":"Morphological changes in rat brain induced by L-cysteine injection in newborn animals","volume":"208","author":"Karlsen","year":"1981","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41537-024-00439-3","article-title":"Parkinson's disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes","volume":"10","author":"Karunakaran","year":"2024","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.neuropharm.2025.110527_bib161","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fneur.2019.00650","article-title":"N-Acetylcysteine amide ameliorates blast-induced changes in blood-brain barrier integrity in rats","volume":"10","author":"Kawoos","year":"2019","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib162","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition","volume":"22","author":"Keller","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib163","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/npr2.12360","article-title":"Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis","volume":"43","author":"Khalatbari Mohseni","year":"2023","journal-title":"Neuropsychopharmacol Rep"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib164","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/neur.2023.0124","article-title":"Combined use of guanfacine and N-acetylcysteine for the treatment of cognitive deficits after traumatic brain injury","volume":"5","author":"Khasnavis","year":"2024","journal-title":"Neurotrauma Rep"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41537-023-00398-1","article-title":"Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia","volume":"9","author":"Kim","year":"2023","journal-title":"Schizophrenia (Heidelb)"},{"issue":"14","key":"10.1016\/j.neuropharm.2025.110527_bib166","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.7150\/ijbs.97723","article-title":"N-acetylcysteine alleviates depressive-like behaviors in adolescent EAAC1(-\/-) mice and early life stress model rats","volume":"20","author":"Kim","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib167","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41467-020-15655-5","article-title":"A double-hit of stress and low-grade inflammation on functional brain network mediates posttraumatic stress symptoms","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110527_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.09.019","article-title":"Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal","volume":"128","author":"Kim","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110527_bib169","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.bioeng.2.1.55","article-title":"Fundamentals of impact biomechanics: Part I--Biomechanics of the head, neck, and thorax","volume":"2","author":"King","year":"2000","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.002","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"21","author":"Klemmensen","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110527_bib171","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","article-title":"The role of cystine-glutamate exchange in nicotine dependence in rats and humans","volume":"65","author":"Knackstedt","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib172","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","article-title":"Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking","volume":"67","author":"Knackstedt","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib173","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib174","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s00204-020-02793-4","article-title":"Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates","volume":"94","author":"Koenderink","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib175","doi-asserted-by":"crossref","first-page":"979","DOI":"10.18632\/aging.100113","article-title":"Antioxidant N-acetyl-L-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1","volume":"1","author":"Kondratov","year":"2009","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib176","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib177","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1089\/ars.2012.4858","article-title":"Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models","volume":"18","author":"Kulak","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib178","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/gerona\/glac135","article-title":"Supplementing Glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial","volume":"78","author":"Kumar","year":"2023","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110527_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8100390","volume":"8","author":"Kumar","year":"2020","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib180","doi-asserted-by":"crossref","DOI":"10.3390\/nu14051114","article-title":"GlyNAC (Glycine and N-acetylcysteine) supplementation in mice increases length of life by correcting glutathione deficiency, oxidative stress, mitochondrial dysfunction, abnormalities in mitophagy and nutrient sensing, and genomic damage","volume":"14","author":"Kumar","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051042","volume":"12","author":"Kumar","year":"2023","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib182","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.biopsych.2011.10.024","article-title":"The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine","volume":"71","author":"Kupchik","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"16","key":"10.1016\/j.neuropharm.2025.110527_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169419","article-title":"Chronic N-acetylcysteine treatment prevents amphetamine-induced hyperactivity in heterozygous Disc1 mutant mice, a putative prodromal schizophrenia animal model","volume":"23","author":"Lai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib184","first-page":"602","article-title":"Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation","volume":"18","author":"Lante","year":"2008","journal-title":"Hippocampus (New York, N. Y.)"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1521-0391.2013.12034.x","article-title":"A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence","volume":"22","author":"LaRowe","year":"2013","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib186","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"Am. J. Addict."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib187","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.2007.164.7.1115","article-title":"Is cocaine desire reduced by N-acetylcysteine?","volume":"164","author":"LaRowe","year":"2007","journal-title":"Am. J. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109563","article-title":"Obesity-induced astrocyte dysfunction impairs heterosynaptic plasticity in the orbitofrontal cortex","volume":"36","author":"Lau","year":"2021","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib189","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/sj.npp.1301624","article-title":"Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients","volume":"33","author":"Lavoie","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110527_bib190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2014.02.006","article-title":"N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies","volume":"81","author":"Lee","year":"2014","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110527_bib191","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1460-9568.1993.tb00926.x","article-title":"Cysteine sulphinate and cysteate: mediators of cysteine toxicity in the neonatal rat brain?","volume":"5","author":"Lehmann","year":"1993","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib192","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/jpet.121.000735","article-title":"Metabotropic glutamate receptor 2\/3 activation improves motor performance and reduces pathology in heterozygous zQ175 Huntington disease mice","volume":"379","author":"Li","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"34","key":"10.1016\/j.neuropharm.2025.110527_bib193","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1523\/JNEUROSCI.1766-07.2007","article-title":"Metabotropic glutamate 2\/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence","volume":"27","author":"Liechti","year":"2007","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib194","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/FBP.0b013e3283512c3a","article-title":"AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension test","volume":"23","author":"Linck","year":"2012","journal-title":"Behav. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib195","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.npp.1300321","article-title":"Anxiolytic activity of the MGLU2\/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions","volume":"29","author":"Linden","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib196","doi-asserted-by":"crossref","first-page":"fcad214","DOI":"10.1093\/braincomms\/fcad214","article-title":"Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington's disease","volume":"5","author":"Liu","year":"2023","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib197","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00213-024-06656-z","article-title":"The effects of N-acetyl cysteine on intrinsic functional connectivity and neural alcohol cue reactivity in treatment-seeking individuals with alcohol use disorder: a preliminary study","volume":"242","author":"Logge","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110527_bib198","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.924955","article-title":"The antioxidant N-Acetyl-L-Cysteine restores the behavioral deficits in a neurodevelopmental model of schizophrenia through a mechanism that involves nitric oxide","volume":"13","author":"Lopes-Rocha","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib199","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.138","article-title":"Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia","volume":"7","author":"Maas","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib200","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1516-44462011000400011","article-title":"N-acetylcysteine for major depressive episodes in bipolar disorder","volume":"33","author":"Magalhaes","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib201","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0004867413481631","article-title":"A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania","volume":"47","author":"Magalhaes","year":"2013","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"10161","key":"10.1016\/j.neuropharm.2025.110527_bib202","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib203","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","article-title":"An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study","volume":"31","author":"Mardikian","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib204","doi-asserted-by":"crossref","first-page":"664","DOI":"10.14336\/AD.2017.0930","article-title":"N-Acetylcysteine treatment reduces age-related hearing loss and memory impairment in the senescence-accelerated prone 8 (SAMP8) mouse model","volume":"9","author":"Marie","year":"2018","journal-title":"Aging Dis"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib205","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.molpharmaceut.6b01028","article-title":"Redox potential-sensitive N-acetyl cysteine-prodrug nanoparticles inhibit the activation of microglia and improve neuronal survival","volume":"14","author":"Markoutsa","year":"2017","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib206","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0006-8993(99)02349-5","article-title":"N-Acetylcysteine delays age-associated memory impairment in mice: role in synaptic mitochondria","volume":"855","author":"Martinez","year":"2000","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinme.2024.100200","article-title":"Huntington's disease: a clinical primer for acute and general physicians","volume":"24","author":"Massey","year":"2024","journal-title":"Clin. Med."},{"issue":"16","key":"10.1016\/j.neuropharm.2025.110527_bib208","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1073\/pnas.91.16.7496","article-title":"N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro","volume":"91","author":"Mayer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib209","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00401-013-1230-6","article-title":"The neuropathology of sport","volume":"127","author":"McKee","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib210","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/TA.0000000000003639","article-title":"N -acetylcysteine is associated with reduction of postconcussive symptoms in elderly patients: a pilot study","volume":"93","author":"McPherson","year":"2022","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.neuropharm.2025.110527_bib211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0076-6879(95)52005-8","article-title":"Glutathione biosynthesis and its inhibition","volume":"252","author":"Meister","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbi.2016.09.008","article-title":"Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study","volume":"59","author":"Metcalf","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib213","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0301-0082(97)00055-5","article-title":"Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging","volume":"54","author":"Michaelis","year":"1998","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib214","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110527_bib215","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/0006-2952(84)90599-9","article-title":"Mechanism of action of paracetamol protective agents in mice in vivo","volume":"33","author":"Miners","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2025.110527_bib216","first-page":"333","article-title":"N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria","volume":"292","author":"Miquel","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib217","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pbb.2015.08.006","article-title":"N-acetylcysteine prevents stress-induced anxiety behavior in zebrafish","volume":"B","author":"Mocelin","year":"2015","journal-title":"Pharmacol Biochem Behav 139 Pt"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib218","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s12035-018-1165-y","article-title":"N-Acetylcysteine Reverses Anxiety and Oxidative Damage Induced by Unpredictable Chronic Stress in Zebrafish","volume":"56","author":"Mocelin","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuropharm.2025.110527_bib219","article-title":"Sustained anxiolytic-like effects of N-acetylcysteine in zebrafish subjected to unpredictable chronic stress","author":"Mocelin","year":"2024","journal-title":"Research Square PREPRINT"},{"issue":"5381","key":"10.1016\/j.neuropharm.2025.110527_bib220","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110527_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2022.102294","article-title":"Protective effect of N-acetyl cysteine on the mitochondrial dynamic imbalance in temporal lobe epilepsy: possible role of mTOR","volume":"96","author":"Mohammadi","year":"2022","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2025.110527_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114263","article-title":"Evaluation the cognition-improvement effects of N-acetyl cysteine in experimental temporal lobe epilepsy in rat","volume":"440","author":"Mohammadi","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib223","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbi.2012.12.011","article-title":"Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine","volume":"30","author":"Moller","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib224","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11011-013-9433-z","article-title":"N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats","volume":"28","author":"Moller","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2025.110527_bib225","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0269881119875979","article-title":"Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia","volume":"34","author":"Monte","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib227","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cpt.1548","article-title":"N-acetyl cysteine is associated with dopaminergic improvement in Parkinson's disease","volume":"106","author":"Monti","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib228","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157602","article-title":"N-acetyl cysteine may support dopamine neurons in Parkinson's disease: preliminary clinical and cell line data","volume":"11","author":"Monti","year":"2016","journal-title":"PLoS One"},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2025.110527_bib229","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuropharm.2016.07.009","article-title":"N-acetylcysteine treatment blocks the development of ethanol-induced behavioural sensitization and related DeltaFosB alterations","volume":"110","author":"Morais-Silva","year":"2016","journal-title":"Neuropharmacology"},{"issue":"27","key":"10.1016\/j.neuropharm.2025.110527_bib230","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","article-title":"Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking","volume":"25","author":"Moran","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110527_bib231","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fnagi.2018.00399","article-title":"N-acetylcysteine prevents the spatial memory deficits and the redox-dependent RyR2 decrease displayed by an alzheimer's disease rat model","volume":"10","author":"More","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib232","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/adb.12443","article-title":"mGluR2\/3 mediates short-term control of nicotine-seeking by acute systemic N-acetylcysteine","volume":"23","author":"Moro","year":"2018","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib233","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nn.2250","article-title":"N-Acetylcysteine reverses cocaine-induced metaplasticity","volume":"12","author":"Moussawi","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib234","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1073\/pnas.1011265108","article-title":"Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse","volume":"108","author":"Moussawi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110527_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.827263","article-title":"Neuroinflammation: a possible link between chronic vascular disorders and neurodegenerative diseases","volume":"14","author":"Moyse","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib236","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12840","article-title":"Tau protein aggregation is associated with cellular senescence in the brain","volume":"17","author":"Musi","year":"2018","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib237","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2017.09.020","article-title":"Role of the astroglial glutamate exchanger xCT in ventral Hippocampus in resilience to stress","volume":"96","author":"Nasca","year":"2017","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib238","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/mp.2014.96","article-title":"Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility","volume":"20","author":"Nasca","year":"2015","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib239","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007168.pub2","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","author":"Nash","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2025.110527_bib240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuroscience.2013.03.032","article-title":"Neuroprotection induced by N-acetylcysteine against cytosolic glutathione depletion-induced Ca2+ influx in dorsal root ganglion neurons of mice: role of TRPV1 channels","volume":"242","author":"Naziroglu","year":"2013","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib241","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10571-014-0069-2","article-title":"Neuroprotection induced by N-acetylcysteine and selenium against traumatic brain injury-induced apoptosis and calcium entry in hippocampus of rat","volume":"34","author":"Naziroglu","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib242","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/acel.12073","article-title":"Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: novel protective role of glutathione","volume":"12","author":"Nguyen","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2025.110527_bib243","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib244","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2014.05.017","article-title":"3-Methyl-1-phenyl-2-pyrazolin-5-one or N-acetylcysteine prevents hippocampal mossy fiber sprouting and rectifies subsequent convulsive susceptibility in a rat model of kainic acid-induced seizure ceased by pentobarbital","volume":"1590","author":"Nomura","year":"2014","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/oxfordjournals.schbul.a033325","article-title":"Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters","volume":"24","author":"O'Donnell","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib246","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jphs.2021.09.001","article-title":"Reduced mitochondrial complex II activity enhances cell death via intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin","volume":"147","author":"Okada","year":"2021","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib247","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01061422","article-title":"Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine","volume":"34","author":"Olsson","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib248","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib249","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/npp.2011.109","article-title":"N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72\/G30 transgenic mice","volume":"36","author":"Otte","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110527_bib250","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.749026","article-title":"From neurodevelopmental to neurodegenerative disorders: the vascular continuum","volume":"13","author":"Ouellette","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110527_bib251","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.expneurol.2014.04.020","article-title":"N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI","volume":"257","author":"Pandya","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib252","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12325-020-01542-4","article-title":"Pharmacokinetics and safety of single and multiple doses of oral N-acetylcysteine in healthy Chinese and caucasian volunteers: an open-label, phase I clinical study","volume":"38","author":"Papi","year":"2021","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib253","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrg3934","article-title":"Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders","volume":"16","author":"Parikshak","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib254","first-page":"1463","article-title":"Impairments in hippocampal synaptic plasticity following prenatal ethanol exposure are dependent on glutathione levels","volume":"23","author":"Patten","year":"2013","journal-title":"Hippocampus (New York, N. Y.)"},{"issue":"7498","key":"10.1016\/j.neuropharm.2025.110527_bib255","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature13136","article-title":"Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease","volume":"509","author":"Paul","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib256","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz130","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"142","author":"Pauletti","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib257","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-006-0372-9","article-title":"The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats","volume":"186","author":"Peters","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib258","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13311-014-0257-2","article-title":"Past and present definitions of epileptogenesis and its biomarkers","volume":"11","author":"Pitkanen","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2025.110527_bib259","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2025.110527_bib260","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.psychres.2018.02.056","article-title":"Effects of adjunctive N-acetylcysteine on depressive symptoms: modulation by baseline high-sensitivity C-reactive protein","volume":"263","author":"Porcu","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib261","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.74","article-title":"Synaptic and cellular changes induced by the schizophrenia susceptibility gene G72 are rescued by N-acetylcysteine treatment","volume":"6","author":"Posfai","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib262","article-title":"Chronic treatment with N-acetylcysteine decreases extinction responding and reduces cue-induced nicotine-seeking","volume":"7","author":"Powell","year":"2019","journal-title":"Phys. Rep."},{"issue":"6198","key":"10.1016\/j.neuropharm.2025.110527_bib263","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bmj.2.6198.1097","article-title":"Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning","volume":"2","author":"Prescott","year":"1979","journal-title":"Br. Med. J."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2025.110527_bib264","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(95)01139-0","article-title":"Neurotoxicity of cysteine: interaction with glutamate","volume":"705","author":"Puka-Sundvall","year":"1995","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib265","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/aps.2009.72","article-title":"Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC)","volume":"30","author":"Qian","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib266","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.biocel.2007.04.014","article-title":"Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes","volume":"39","author":"Raftos","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib267","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresbull.2015.02.007","article-title":"N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: an investigation into the interaction of parkin and Drp1 proteins","volume":"113","author":"Rahimmi","year":"2015","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib268","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00213-012-2837-3","article-title":"N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking","volume":"225","author":"Ramirez-Nino","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110527_bib269","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pnpbp.2014.10.002","article-title":"Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia","volume":"57","author":"Rapado-Castro","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib270","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1017\/S0033291716002932","article-title":"Cognitive effects of adjunctive N-acetyl cysteine in psychosis","volume":"47","author":"Rapado-Castro","year":"2017","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib271","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.111.179317","article-title":"Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking","volume":"337","author":"Reichel","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110527_bib272","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2012.07.026","article-title":"BDNF may play a differential role in the protective effect of the mGluR2\/3 agonist LY379268 on striatal projection neurons in R6\/2 Huntington's disease mice","volume":"1473","author":"Reiner","year":"2012","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib273","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00210-019-01762-8","article-title":"Effects of N-acetylcysteine amide on anxiety and stress behavior in zebrafish","volume":"393","author":"Reis","year":"2020","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib274","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/adb.12127","article-title":"Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement","volume":"20","author":"Reissner","year":"2015","journal-title":"Addict. Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41582-022-00635-8","article-title":"Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits","volume":"18","author":"Ressler","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib276","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nut.2018.03.006","article-title":"omega-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress","volume":"53","author":"Reus","year":"2018","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib277","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JPD-230176","article-title":"Investigating the shared genetic etiology between Parkinson's disease and depression","volume":"14","author":"Reyes-Perez","year":"2024","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib278","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0021-9258(19)41830-9","article-title":"Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione","volume":"250","author":"Richman","year":"1975","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib279","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamapsychiatry.2021.4377","article-title":"Longitudinal associations of mental disorders with dementia: 30-year analysis of 1.7 million New Zealand citizens","volume":"79","author":"Richmond-Rakerd","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020676","article-title":"Glutathione restores the mechanism of synaptic plasticity in aged mice to that of the adult","volume":"6","author":"Robillard","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib281","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12040970","article-title":"Maternal supplementation with N-acetylcysteine modulates the microbiota-gut-brain Axis in offspring of the poly I:C rat model of schizophrenia","volume":"12","author":"Romero-Miguel","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib282","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41398-023-02652-7","article-title":"N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia","volume":"14","author":"Romero-Miguel","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib283","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","article-title":"Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003","volume":"162","author":"Ropacki","year":"2005","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib284","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.addbeh.2012.11.003","article-title":"Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial","volume":"38","author":"Roten","year":"2013","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib285","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib286","doi-asserted-by":"crossref","first-page":"320","DOI":"10.9758\/cpn.2023.21.2.320","article-title":"The impact of N-acetylcysteine on major depression: qualitative observation and mixed methods analysis of participant change during a 12-week randomised controlled trial","volume":"21","author":"Russell","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib287","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0304-4165(82)90302-6","article-title":"The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes","volume":"719","author":"Saez","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib288","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043798","article-title":"N-acetylcysteine suppresses microglial inflammation and induces mortality dose-dependently via tumor necrosis factor-alpha signaling","volume":"24","author":"Sakai","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib289","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000334273","article-title":"N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease","volume":"9","author":"Sandhir","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"1\u20134","key":"10.1016\/j.neuropharm.2025.110527_bib291","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000334901","article-title":"The antioxidant N-acetylcysteine prevents the mitochondrial fragmentation induced by soluble amyloid-beta peptide oligomers","volume":"10","author":"Sanmartin","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2025.110527_bib292","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbr.2016.10.010","article-title":"Anxiolytic properties of N-acetylcysteine in mice","volume":"317","author":"Santos","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib293","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12031-013-0064-y","article-title":"Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats","volume":"51","author":"Sari","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110527_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110550","article-title":"N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: a phase III, 20-week, double-blind, randomized, placebo-controlled trial","volume":"117","author":"Sarris","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib295","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia (Cph.)"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib296","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2012.66","article-title":"N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study","volume":"37","author":"Schmaal","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib297","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.alcohol.2015.01.009","article-title":"N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats","volume":"49","author":"Schneider","year":"2015","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110527_bib298","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addbeh.2017.11.044","article-title":"The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment","volume":"79","author":"Schulte","year":"2018","journal-title":"Addict. Behav."},{"issue":"25","key":"10.1016\/j.neuropharm.2025.110527_bib299","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1074\/jbc.M114.565242","article-title":"Na+ interactions with the neutral amino acid transporter ASCT1","volume":"289","author":"Scopelliti","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib300","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.52.2.426","article-title":"N-acetylcysteine therapy for Unverricht-Lundborg disease","volume":"52","author":"Selwa","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib301","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11064-014-1255-9","article-title":"N-acetylcysteine and selenium modulate oxidative stress, antioxidant vitamin and cytokine values in traumatic brain injury-induced rats","volume":"39","author":"Senol","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib302","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pnpbp.2017.11.001","article-title":"Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: a double-blind, randomized clinical trial","volume":"82","author":"Sepehrmanesh","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib303","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainresbull.2017.04.001","article-title":"Influence of N-acetyl cysteine on beta-amyloid-induced Alzheimer's disease in a rat model: a behavioral and electrophysiological study","volume":"131","author":"Shahidi","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib304","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1152\/jn.1998.79.1.334","article-title":"Aging differentially alters forms of long-term potentiation in rat hippocampal area CA1","volume":"79","author":"Shankar","year":"1998","journal-title":"J. Neurophysiol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110527_bib305","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.18632\/aging.101561","article-title":"Effects of N-acetyl-L-cysteine on lifespan, locomotor activity and stress-resistance of 3 Drosophila species with different lifespans","volume":"10","author":"Shaposhnikov","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuropharm.2025.110527_bib306","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1749-6632.1963.tb16647.x","article-title":"The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine","volume":"106","author":"Sheffner","year":"1963","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib307","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S1461145712001071","article-title":"Reduced LTP and LTD in prefrontal cortex synapses in the nucleus accumbens after heroin self-administration","volume":"16","author":"Shen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib308","doi-asserted-by":"crossref","first-page":"263","DOI":"10.31887\/DCNS.2011.13.2\/jsherin","article-title":"Post-traumatic stress disorder: the neurobiological impact of psychological trauma","volume":"13","author":"Sherin","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib309","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/ajad.12503","article-title":"Gender differences among treatment-seeking adults with cannabis use disorder: clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study","volume":"26","author":"Sherman","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2025.110527_bib310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172957","article-title":"Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset","volume":"873","author":"Sid-Otmane","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.neuropharm.2025.110527_bib311","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141812","article-title":"Heroin self-administration and extinction increase prelimbic cortical astrocyte-synapse proximity and alter dendritic spine morphometrics that are reversed by N-acetylcysteine","volume":"12","author":"Siemsen","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2025.110527_bib312","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.neuroscience.2019.03.040","article-title":"Effects of methamphetamine self-administration and extinction on astrocyte structure and function in the nucleus accumbens core","volume":"406","author":"Siemsen","year":"2019","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2025.110527_bib313","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2011.06.030","article-title":"The involvement of Na+, K+-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury","volume":"308","author":"Silva","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib314","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neubiorev.2017.04.013","article-title":"The effect of N-acetylcysteine (NAC) on human cognition - a systematic review","volume":"78","author":"Skvarc","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib316","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pnpbp.2012.06.018","article-title":"N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats","volume":"39","author":"Smaga","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib317","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1237869","article-title":"Effects of N-acetylcysteine on aging cell and obesity complications in obese adults: a randomized, double-blind clinical trial","volume":"10","author":"Sohouli","year":"2023","journal-title":"Front. Nutr."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110527_bib318","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.biopsych.2018.04.016","article-title":"A model of delta(9)-tetrahydrocannabinol self-administration and reinstatement that alters synaptic plasticity in nucleus accumbens","volume":"84","author":"Spencer","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib319","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addbeh.2016.08.001","article-title":"Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation","volume":"63","author":"Squeglia","year":"2016","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110527_bib320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2017.12.005","article-title":"The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial","volume":"185","author":"Squeglia","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib321","first-page":"97","article-title":"Glutathione synthesis is not involved in protection by N-acetylcysteine against UVB-induced systemic immunosuppression in mice","volume":"68","author":"Steenvoorden","year":"1998","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib322","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fncel.2015.00258","article-title":"Understanding the role of P2X7 in affective disorders-are glial cells the major players?","volume":"9","author":"Stokes","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110527_bib323","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2014.04.024","article-title":"Reevaluation of the rate constants for the reaction of hypochlorous acid (HOCl) with cysteine, methionine, and peptide derivatives using a new competition kinetic approach","volume":"73","author":"Storkey","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib324","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/cap.2012.0066","article-title":"Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxiety","volume":"22","author":"Strawn","year":"2012","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"24","key":"10.1016\/j.neuropharm.2025.110527_bib325","first-page":"12103","article-title":"Phase I study of the pharmacokinetics and safety of single and multiple doses of intravenous N-acetylcysteine in healthy Chinese subjects","volume":"27","author":"Sun","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib326","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s12035-021-02720-3","article-title":"N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG\/Rij rat model of absence epilepsy","volume":"59","author":"Tallarico","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib327","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbr.2014.12.005","article-title":"N-acetyl cysteine does not modify the sensitization of the rewarding effect of amphetamine as assessed with frequency-modulated 50-kHz vocalization in the rat","volume":"280","author":"Taracha","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib328","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10060967","article-title":"N-acetylcysteine (NAC): impacts on human health","volume":"10","author":"Tenorio","year":"2021","journal-title":"Antioxidants"},{"issue":"20","key":"10.1016\/j.neuropharm.2025.110527_bib329","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00924-20","article-title":"Human immunodeficiency virus type 1 and methamphetamine-mediated mitochondrial damage and neuronal degeneration in human neurons","volume":"94","author":"Teodorof-Diedrich","year":"2020","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib330","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib331","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-019-05384-z","article-title":"Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder","volume":"237","author":"Tomko","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"36","key":"10.1016\/j.neuropharm.2025.110527_bib332","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1523\/JNEUROSCI.1976-12.2012","article-title":"Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training","volume":"32","author":"Trantham-Davidson","year":"2012","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib333","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2025.110527_bib335","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nlm.2017.05.005","article-title":"Inactivation of basolateral amygdala prevents chronic immobilization stress-induced memory impairment and associated changes in corticosterone levels","volume":"142","author":"Tripathi","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2025.110527_bib336","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pnpbp.2018.07.016","article-title":"Basolateral amygdalar inactivation blocks chronic stress-induced lamina-specific reduction in prefrontal cortex volume and associated anxiety-like behavior","volume":"88","author":"Tripathi","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib337","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchemneu.2017.12.006","article-title":"Prevention of chronic immobilization stress-induced enhanced expression of glucocorticoid receptors in the prefrontal cortex by inactivation of basolateral amygdala","volume":"95","author":"Tripathi","year":"2019","journal-title":"J. Chem. Neuroanat."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib338","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/10715762.2015.1089988","article-title":"One- and two-electron oxidation of thiols: mechanisms, kinetics and biological fates","volume":"50","author":"Trujillo","year":"2016","journal-title":"Free Radic. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib339","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1472-8206.2006.00401.x","article-title":"Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine","volume":"20","author":"Uma Devi","year":"2006","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib340","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/WNR.0b013e32834d92e6","article-title":"Reagents that block neuronal death from Huntington's disease also curb oxidative stress","volume":"23","author":"Valencia","year":"2012","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib341","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.pnpbp.2008.02.012","article-title":"Effect of N-acetylcysteine and\/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania","volume":"32","author":"Valvassori","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110527_bib342","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/0006-2952(87)90132-8","article-title":"The mechanism of prevention of paracetamol-induced hepatotoxicity by 3,5-dialkyl substitution. The roles of glutathione depletion and oxidative stress","volume":"36","author":"van de Straat","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib343","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.bp.114.148403","article-title":"Longitudinal course of behavioural and psychological symptoms of dementia: systematic review","volume":"209","author":"van der Linde","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib344","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","article-title":"Mechanisms of glutamate transport","volume":"93","author":"Vandenberg","year":"2013","journal-title":"Physiol. Rev."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110527_bib345","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1039\/D4TB00521J","article-title":"Lipid-polymer hybrid nanoparticles loaded with N-acetylcysteine for the modulation of neuroinflammatory biomarkers in human iPSC-derived PSEN2 (N141I) astrocytes as a model of Alzheimer's disease","volume":"12","author":"Vargas-Barona","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.neuropharm.2025.110527_bib346","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1282198","article-title":"Treatment effects of N-acetyl cysteine on resting-state functional MRI and cognitive performance in patients with chronic mild traumatic brain injury: a longitudinal study","volume":"15","author":"Vedaei","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib347","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2025.110527_bib348","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136420","article-title":"N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian rat","volume":"770","author":"Virel","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib349","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mad.2008.01.004","article-title":"Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients","volume":"129","author":"Voghel","year":"2008","journal-title":"Mech. Ageing Dev."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib350","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/wps.21073","article-title":"Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention","volume":"22","author":"Volkow","year":"2023","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110527_bib351","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archgenpsychiatry.2009.50","article-title":"Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study","volume":"66","author":"Vreeburg","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib352","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fphar.2012.00189","article-title":"Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases","volume":"3","author":"Wang","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110527_bib353","article-title":"Inflammatory cytokines changed in patients with depression before and after repetitive transcranial magnetic stimulation treatment","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110527_bib354","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.freeradbiomed.2013.05.043","article-title":"N-Acetylcysteine and allopurinol up-regulated the Jak\/STAT3 and PI3K\/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes","volume":"63","author":"Wang","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2025.110527_bib355","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2024.05.005","article-title":"Prophylactic effects of n-acethylcysteine on inflammation-induced depression-like behaviors in mice","volume":"549","author":"Wang","year":"2024","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib356","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41390-019-0728-6","article-title":"N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats","volume":"88","author":"Ward","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2025.110527_bib357","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0022-5223(19)32956-3","article-title":"Clinical evaluaton of a new mucolytic agent, acetyl-cysteine","volume":"44","author":"Webb","year":"1962","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"39","key":"10.1016\/j.neuropharm.2025.110527_bib358","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo4662","article-title":"Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration","volume":"8","author":"Welch","year":"2022","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib359","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1179\/135100009X392539","article-title":"Role of N-acetylcysteine and cystine in glutathione synthesis in human erythrocytes","volume":"14","author":"Whillier","year":"2009","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuropharm.2025.110527_bib360","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113816","article-title":"Delayed dosing of minocycline plus N-acetylcysteine reduces neurodegeneration in distal brain regions and restores spatial memory after experimental traumatic brain injury","volume":"345","author":"Whitney","year":"2021","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110527_bib361","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jpeds.2014.06.044","article-title":"Antenatal pharmacokinetics and placental transfer of N-acetylcysteine in chorioamnionitis for fetal neuroprotection","volume":"165","author":"Wiest","year":"2014","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib362","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0021-9150(95)05635-1","article-title":"N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels","volume":"119","author":"Wiklund","year":"1996","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.neuropharm.2025.110527_bib363","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1073\/pnas.79.20.6246","article-title":"Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis","volume":"79","author":"Williamson","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib364","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41467-022-31873-5","article-title":"Shared mechanisms across the major psychiatric and neurodegenerative diseases","volume":"13","author":"Wingo","year":"2022","journal-title":"Nat. Commun."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2025.110527_bib365","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0891-5849(99)00051-9","article-title":"Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide","volume":"27","author":"Winterbourn","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib366","doi-asserted-by":"crossref","DOI":"10.1111\/adb.70001","article-title":"N-acetylcysteine as a treatment for substance use cravings: a meta-analysis","volume":"29","author":"Winterlind","year":"2024","journal-title":"Addict. Biol."},{"issue":"14","key":"10.1016\/j.neuropharm.2025.110527_bib367","first-page":"2923","article-title":"N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease","volume":"25","author":"Wright","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2025.110527_bib368","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington's disease","volume":"5","author":"Wright","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110527_bib369","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41401-021-00661-0","article-title":"N-acetylcysteine facilitates extinction of cued fear memory in rats via reestablishing basolateral amygdala glutathione homeostasis","volume":"43","author":"Wu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib370","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2009.09.014","article-title":"Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-L-cysteine capped quantum dots","volume":"31","author":"Xiao","year":"2010","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110527_bib371","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/neu.1999.16.1067","article-title":"Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats","volume":"16","author":"Xiong","year":"1999","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuropharm.2025.110527_bib372","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3389\/fpsyt.2018.00696","article-title":"Metoprolol, N-acetylcysteine, and escitalopram prevents chronic unpredictable mild stress-induced depression by inhibition of endoplasmic reticulum stress","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110527_bib373","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2022.111515","article-title":"N-Acetylcysteine effects on glutathione and glutamate in schizophrenia: a preliminary MRS study","volume":"325","author":"Yang","year":"2022","journal-title":"Psychiatry Res. Neuroimaging."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib374","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuint.2005.12.001","article-title":"Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury","volume":"48","author":"Yi","year":"2006","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110527_bib375","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004867419893439","article-title":"Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia","volume":"54","author":"Yolland","year":"2020","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib376","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WNR.0000000000000948","article-title":"Inhibition of myeloperoxidase by N-acetyl lysyltyrosylcysteine amide reduces experimental autoimmune encephalomyelitis-induced injury and promotes oligodendrocyte regeneration and neurogenesis in a murine model of progressive multiple sclerosis","volume":"29","author":"Yu","year":"2018","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110527_bib377","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-023-00336-2","article-title":"Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial","volume":"12","author":"Yulug","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110527_bib378","first-page":"1655","article-title":"Opposite in vivo effects of agents that stimulate or inhibit the glutamate\/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Ass","volume":"26","author":"Zhang","year":"2016","journal-title":"Hippocampus (New York, N. Y.)"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110527_bib379","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/acs.chemrestox.9b00152","article-title":"N-acetylcysteine: antioxidant, aldehyde scavenger, and more","volume":"32","author":"Zhitkovich","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib380","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biopsych.2007.06.008","article-title":"N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking","volume":"63","author":"Zhou","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110527_bib381","series-title":"N-acetylcysteine Modulates ATF4 Methylation to Alleviate Cognitive Impairments in PTSD Mice","author":"Zhou","year":"2024"},{"key":"10.1016\/j.neuropharm.2025.110527_bib334","doi-asserted-by":"crossref","first-page":"104858","DOI":"10.1016\/j.neuint.2020.104858","article-title":"Remediation of chronic immobilization stress-induced negative affective behaviors and altered metabolism of monoamines in the prefrontal cortex by inactivation of basolateral amygdala","volume":"141","author":"Tripathi","year":"2020","journal-title":"Neurochem Int"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110527_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/da.22711","article-title":"Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries","volume":"35","author":"Alonso","year":"2018","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.neuropharm.2025.110527_bib382","doi-asserted-by":"crossref","first-page":"114252","DOI":"10.1016\/j.expneurol.2022.114252","article-title":"Traumatic axonopathy in spinal tracts after impact acceleration head injury: Ultrastructural observations and evidence of SARM1-dependent axonal degeneration","volume":"359","author":"Alexandris","year":"2023","journal-title":"Exp Neurol"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:26:19Z","timestamp":1779614779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":382,"alternative-id":["S0028390825002333"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110527","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuroprotective effects of N-acetylcysteine in psychiatric and neurodegenerative disorders: From modulation of glutamatergic transmission to restoration of synaptic plasticity","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110527"}}